These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27287)

  • 1. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
    Minneman KP; Quik M; Emson PC
    Brain Res; 1978 Aug; 151(3):507-21. PubMed ID: 27287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration.
    Zahniser NR; Minneman KP; Molinoff PB
    Brain Res; 1979 Dec; 178(2-3):589-95. PubMed ID: 228797
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal lesions with kainic acid: neurochemical characteristics.
    Schwarcz R; Coyle JT
    Brain Res; 1977 May; 127(2):235-49. PubMed ID: 16686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
    Quik M; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of morphine of prostaglandin E2 (PGE2)-sensitive adenylate cyclase in corpus striatum of rats and its cellular localization by using kainic acid.
    Havemann U; Kuschinsky K
    Brain Res; 1978 Jul; 150(2):441-5. PubMed ID: 209852
    [No Abstract]   [Full Text] [Related]  

  • 8. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
    Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
    Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intrastriatal kainic acid injection on [3H]dopamine metabolism in rat striatal slices: evidence for postsynaptic glial cell metabolism by both the type A and B forms of monoamine oxidase.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1983 May; 40(5):1340-8. PubMed ID: 6131940
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of kainic acid in the localization of enzymes in the substantia nigra.
    Nagy JI; Vincent SR; Lehmann J; Fibiger HC; McGeer EG
    Brain Res; 1978 Jun; 149(2):431-41. PubMed ID: 27284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence that nonneuronal beta-adrenoceptors as well as dopamine receptors contribute to cyclic AMP efflux in rat striatum.
    Suyama K; Dykstra KH; Masana MI; Manji HK; Potter WZ
    J Neurochem; 1994 May; 62(5):1734-40. PubMed ID: 8158123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid.
    Friedle NM; Kelly PH; Moore KE
    Br J Pharmacol; 1978 May; 63(1):151-8. PubMed ID: 148306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain.
    Quik M; Emson PC; Fahrenkrug J; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):281-6. PubMed ID: 38409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum.
    Biziere K; Coyle JT
    J Neurosci Res; 1979; 4(5-6):383-98. PubMed ID: 42811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the localization of [3H]sulpiride binding sites in rat striatal membranes.
    Freedman SB; Mustafa AA; Poat JA; Senior KA; Wait CP; Woodruff GN
    Neuropharmacology; 1981 Dec; 20(12A):1151-5. PubMed ID: 6119635
    [No Abstract]   [Full Text] [Related]  

  • 16. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic taurine effects on various neurochemical indices in control and kainic acid-lesioned neostriatum.
    Sanberg PR; Staines W; McGeer EG
    Brain Res; 1979 Feb; 161(2):367-70. PubMed ID: 31967
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term sequelae of striatal kainate lesion.
    Zaczek R; Schwarcz R; Coyle JT
    Brain Res; 1978 Sep; 152(3):626-32. PubMed ID: 28812
    [No Abstract]   [Full Text] [Related]  

  • 19. Kainic acid lesions decrease striatal dopamine receptors and 1,4-dihydropyridine sites.
    Skattebøl A; Hruska RE; Hawthorn M; Triggle DJ
    Neurosci Lett; 1988 Jun; 89(1):85-9. PubMed ID: 2456499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
    Cross AJ; Waddington JL
    Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.